Trial intelligence / Profile preview

Fenoterol vs Cold Exposure to Activate Brown Adipose Tissue

NCT05294965Phase 1Completed

Sponsor
University Hospital Basel
Start
Apr 2022
Primary completion
Mar 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of fenoterol in obesity (2 arms), sponsored by University Hospital Basel. Primary endpoint: Brown Adipose Tissue Mean Standardized Uptake Value. Started Apr 2022; status: completed.

02

Drugs

fenoterol
03

Conditions

obesity

Beyond the preview

Go deeper on NCT05294965.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05294965.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call